当前位置:首页 - 行情中心 - 毕得医药(688073) - 财务分析 - 现金流量表

毕得医药

(688073)

  

流通市值:50.21亿  总市值:50.21亿
流通股本:9088.29万   总股本:9088.29万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金339,186,076.921,390,422,606.81929,154,255.85586,736,609.13
  收到的税费返还18,627,108.7458,380,404.2240,429,228.3426,658,135.85
  收到其他与经营活动有关的现金5,603,930.9532,097,312.8327,621,571.6717,768,672.67
  经营活动现金流入小计363,417,116.611,480,900,323.86997,205,055.86631,163,417.65
  购买商品、接受劳务支付的现金230,829,051.991,096,532,777.85747,272,107.11463,776,403.62
  支付给职工以及为职工支付的现金50,988,612.73191,194,781.07134,615,488.4889,201,273.5
  支付的各项税费19,238,595.2972,729,944.2838,142,548.6926,321,524.01
  支付其他与经营活动有关的现金22,929,938.8692,118,605.3568,442,207.235,752,027.93
  经营活动现金流出小计323,986,198.871,452,576,108.55988,472,351.48615,051,229.06
  经营活动产生的现金流量净额39,430,917.7428,324,215.318,732,704.3816,112,188.59
二、投资活动产生的现金流量:
  收回投资收到的现金460,009,535.314,227,594,468.943,339,081,843.861,991,444,472.63
  取得投资收益收到的现金696,350.688,880,517.754,708,553.482,766,843.68
  处置固定资产、无形资产和其他长期资产收回的现金净额12,683,830.4310,052,865.112,758,643.342,798,776.36
  收到的其他与投资活动有关的现金8,000,00014,480,00011,644,185.164,208,951
  投资活动现金流入小计481,389,716.424,261,007,851.793,368,193,225.842,001,219,043.67
  购建固定资产、无形资产和其他长期资产支付的现金1,769,110.9424,283,902.112,702,136.865,875,730.96
  投资支付的现金570,000,0004,282,375,4673,457,375,4672,377,375,467
  取得子公司及其他营业单位支付的现金1,771,366.47,016,125.46--
  支付其他与投资活动有关的现金-22,480,000.2216,544,185.216,544,185.2
  投资活动现金流出小计573,540,477.344,336,155,494.783,486,621,789.062,399,795,383.16
  投资活动产生的现金流量净额-92,150,760.92-75,147,642.99-118,428,563.22-398,576,339.49
三、筹资活动产生的现金流量:
  取得借款收到的现金137,099.4250,709,341.29276,952,760.48268,028,272.07
  收到其他与筹资活动有关的现金-4,982,515.562,982,515.562,982,515.56
  筹资活动现金流入小计137,099.4255,691,856.85279,935,276.04271,010,787.63
  偿还债务支付的现金2,591,215.45194,282,470.22118,645,192.1898,057,882.15
  分配股利、利润或偿付利息支付的现金659,336.4279,786,387.2878,888,900.5878,329,965.84
  支付其他与筹资活动有关的现金3,785,671.68119,658,025.44112,321,417.35102,040,775.16
  筹资活动现金流出小计7,036,223.55393,726,882.94309,855,510.11278,428,623.15
  筹资活动产生的现金流量净额-6,899,124.15-138,035,026.09-29,920,234.07-7,417,835.52
四、汇率变动对现金及现金等价物的影响-8,910,177.57-8,774,772.59-3,268,217.273,350,488.57
五、现金及现金等价物净增加额-68,529,144.9-193,633,226.36-142,884,310.18-386,531,497.85
  加:期初现金及现金等价物余额902,987,471.891,096,620,698.251,096,620,698.251,096,620,698.25
  期末现金及现金等价物余额834,458,326.99902,987,471.89953,736,388.07710,089,200.4
补充资料:
  净利润-151,739,651.59-73,406,059.54
  资产减值准备-41,022,275.45-18,647,601.9
  固定资产和投资性房地产折旧-13,985,751.95-6,473,364.27
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-13,985,751.95-6,473,364.27
  无形资产摊销-497,471.38-235,135.83
  长期待摊费用摊销-9,381,954.28-5,023,424.01
  处置固定资产、无形资产和其他长期资产的损失--3,898,219.62--330,567.88
  固定资产报废损失-1,113,604.89--
  公允价值变动损失--2,599,122.99--742,557.99
  财务费用-13,228,303.72-6,351,997.46
  投资损失--7,983,317.65--6,707,093.94
  递延所得税--4,748,763.14--3,552,891.63
  其中:递延所得税资产减少--5,254,090.31--1,778,637.35
    递延所得税负债增加-505,327.17--1,774,254.28
  存货的减少--231,935,304.96--107,216,108.43
  经营性应收项目的减少--29,757,507.3--6,627,240.26
  经营性应付项目的增加-24,935,738.22-19,658,046.64
  其他-33,509,597.5--
  不涉及现金收支的投资和筹资活动金额其他项目-16,533,081.74-525,818.16
  现金的期末余额-902,987,471.89-710,089,200.4
  减:现金的期初余额-1,096,620,698.25-1,096,620,698.25
  现金及现金等价物的净增加额--193,633,226.36--386,531,497.85
公告日期2026-04-302026-04-232025-10-302025-08-22
审计意见(境内)标准无保留意见
TOP↑